XML 50 R34.htm IDEA: XBRL DOCUMENT
v3.26.1

Accrued Expenses and Other Current Liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accrued Expenses and Other Current Liabilities |
Schedule of accrued expenses and other current liabilities | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ | ​ ​ ​ | 2025 | ​ ​ ​ | 2024
Accrued dividend | ​ | $ | 792,616 | ​ | $ | —
Accrued rework of clinical supply returns |  | ​ | 250,000 |  | ​ | 250,000
Accrued franchise tax |  | ​ | 193,052 |  | ​ | —
Accrued compensation expense | ​ | ​ | 190,709 | ​ | ​ | 144,161
Accrued research and development expenses |  | ​ | 176,948 |  | ​ | 302,880
Accrued professional services | ​ | ​ | 157,770 | ​ | ​ | 111,750
Accrued foreign tax | ​ | ​ | 100,000 | ​ | ​ | 295,711
Other accrued expenses | ​ | ​ | 10,011 | ​ | ​ | 218,172
Total accrued expenses and other current liabilities | ​ | $ | 1,871,106 | ​ | $ | 1,322,674
​

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration